PHARMACY HEALTH BUDESONIDE HAYFEVER budesonide 32 microgram/actuation suspension bottle

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

budesonide, Quantity: 0.64 g/L

Verfügbar ab:

Arrotex Pharmaceuticals Pty Ltd

INN (Internationale Bezeichnung):

Budesonide

Darreichungsform:

Spray, suspension

Zusammensetzung:

Excipient Ingredients: purified water; hydrochloric acid; glucose monohydrate; potassium sorbate; disodium edetate; polysorbate 80; microcrystalline cellulose; carmellose sodium

Verabreichungsweg:

Nasal

Einheiten im Paket:

120 doses

Verschreibungstyp:

(S2) Pharmacy Medicine

Anwendungsgebiete:

For short term (3-6 months) prophylaxis or treatment of seasonal allergic rhinitis in adults and children,aged 12 years and over and perennial allergic rhinitis in adults 18 years and over.

Produktbesonderheiten:

Visual Identification: White suspension; Container Type: Aerosol - Pump Actuated Metered Dose; Container Material: Glass Type III Coloured; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2017-05-18